Fysik & material
6.6
Heart Device Failures Linked to Overlooked Blood Vessel Damage
Researchers have identified a biological marker that predicts which heart device patients will struggle after implantation, potentially saving money and lives. The finding could reshape how doctors select and monitor patients receiving cardiac resynchronization therapy devices, a $2+ billion annual market.
Originaltitel: Endothelial Dysfunction Drives CRTd Outcome at 1-Year Follow-Up: A Novel Role as Biomarker for miR-130a-5p